Seach Medical Group Ltd (TLV:SEMG)
Israel
· Delayed Price · Currency is ILS · Price in ILA 250.00
+2.00 (0.81%)
Apr 1, 2025, 1:13 PM IDT
Seach Medical Group Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Revenue | 171.72 | 150.32 | 134.21 | 67.34 | 36.8 | Upgrade
|
| Revenue Growth (YoY) | 14.24% | 12.01% | 99.30% | 82.98% | 27.63% | Upgrade
|
| Cost of Revenue | 114.09 | 112.93 | 95.91 | 44.34 | 19.86 | Upgrade
|
| Gross Profit | 57.63 | 37.4 | 38.3 | 23 | 16.94 | Upgrade
|
| Selling, General & Admin | 37.75 | 38.23 | 32.74 | 16.16 | 10.57 | Upgrade
|
| Research & Development | 0.98 | 1.76 | 1.45 | 2.31 | 1.93 | Upgrade
|
| Other Operating Expenses | 1.12 | -0.23 | 0.08 | 0.12 | -0.24 | Upgrade
|
| Operating Expenses | 39.85 | 39.76 | 34.27 | 18.59 | 12.25 | Upgrade
|
| Operating Income | 17.79 | -2.37 | 4.03 | 4.41 | 4.69 | Upgrade
|
| Interest Expense | -2.3 | -1.81 | -0.94 | -0.17 | -0.09 | Upgrade
|
| Interest & Investment Income | 0.44 | 0.25 | 0.01 | 0.25 | 0.41 | Upgrade
|
| Earnings From Equity Investments | -0.27 | 0.19 | -1.24 | -1 | -1.55 | Upgrade
|
| Other Non Operating Income (Expenses) | - | -0.88 | -0.73 | -0.25 | -0.61 | Upgrade
|
| EBT Excluding Unusual Items | 15.66 | -4.61 | 1.14 | 3.24 | 2.83 | Upgrade
|
| Impairment of Goodwill | -2.27 | -5.76 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.04 | -2.03 | -5.04 | 0.49 | 6.12 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -0.32 | -0.17 | 0.01 | - | Upgrade
|
| Other Unusual Items | - | 2.44 | 0 | 2.49 | 4.35 | Upgrade
|
| Pretax Income | 13.42 | -10.28 | -4.07 | 6.23 | 13.3 | Upgrade
|
| Income Tax Expense | -0.14 | 1.59 | 1.2 | 1.01 | 1.33 | Upgrade
|
| Earnings From Continuing Operations | 13.56 | -11.87 | -5.27 | 5.23 | 11.97 | Upgrade
|
| Minority Interest in Earnings | -0.03 | 1.36 | 1.86 | 0.12 | - | Upgrade
|
| Net Income | 13.52 | -10.51 | -3.41 | 5.35 | 11.97 | Upgrade
|
| Net Income to Common | 13.52 | -10.51 | -3.41 | 5.35 | 11.97 | Upgrade
|
| Net Income Growth | - | - | - | -55.30% | - | Upgrade
|
| Shares Outstanding (Basic) | 34 | 34 | 34 | 34 | 33 | Upgrade
|
| Shares Outstanding (Diluted) | 34 | 34 | 34 | 34 | 33 | Upgrade
|
| Shares Change (YoY) | -0.63% | - | 0.78% | 3.61% | 23.40% | Upgrade
|
| EPS (Basic) | 0.40 | -0.31 | -0.10 | 0.16 | 0.37 | Upgrade
|
| EPS (Diluted) | 0.40 | -0.31 | -0.10 | 0.16 | 0.37 | Upgrade
|
| EPS Growth | - | - | - | -56.86% | - | Upgrade
|
| Free Cash Flow | 15.54 | -0.67 | 16.16 | -10.02 | -10.23 | Upgrade
|
| Free Cash Flow Per Share | 0.46 | -0.02 | 0.47 | -0.30 | -0.31 | Upgrade
|
| Gross Margin | 33.56% | 24.88% | 28.54% | 34.16% | 46.04% | Upgrade
|
| Operating Margin | 10.36% | -1.57% | 3.00% | 6.55% | 12.74% | Upgrade
|
| Profit Margin | 7.88% | -6.99% | -2.54% | 7.94% | 32.52% | Upgrade
|
| Free Cash Flow Margin | 9.05% | -0.44% | 12.04% | -14.88% | -27.80% | Upgrade
|
| EBITDA | 20.09 | 1.29 | 9.28 | 7.39 | 6.16 | Upgrade
|
| EBITDA Margin | 11.70% | 0.86% | 6.92% | 10.97% | 16.73% | Upgrade
|
| D&A For EBITDA | 2.31 | 3.66 | 5.25 | 2.98 | 1.47 | Upgrade
|
| EBIT | 17.79 | -2.37 | 4.03 | 4.41 | 4.69 | Upgrade
|
| EBIT Margin | 10.36% | -1.57% | 3.00% | 6.55% | 12.74% | Upgrade
|
| Effective Tax Rate | - | - | - | 16.14% | 10.02% | Upgrade
|
Updated Nov 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.